Items where authors include "Rabin, N."

Article

Briggs, A.H., Doyle-Connolly, A., Schneider, J. et al. (8 more authors) (2025) An attribution of value framework for combination treatments. Value in Health, 28 (1). pp. 72-80. ISSN 1098-3015

Buckle, C.H., De Leenheer, E., Lawson, M.A. et al. (5 more authors) (2012) Soluble Rank Ligand Produced by Myeloma Cells Causes Generalised Bone Loss in Multiple Myeloma. PLoS ONE, 7 (8). e41127. ISSN 1932-6203

Conference abstract

Pawlyn, C., Royle, K.-L. orcid.org/0000-0003-0225-1199, Senior, E. et al. (20 more authors) (2025) Is IMWG frailty-score-adjusted dosing the right approach to improve toxicity and outcomes in FRAIL patients? Results from the UK-MRA FiTNEss trial in newly diagnosed myeloma patients ineligible for ASCT. [Conference abstract]

Dawkins, B., Gkountouras, G., Meads, D. et al. (21 more authors) (2024) Cost-Effectiveness of Frailty-Adjusted Therapy in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma - an Economic Evaluation of the Fitness Trial. [Conference abstract]

Cook, G., Pawlyn, C., Royle, K.-L. et al. (20 more authors) (2024) IMWG Frailty Score-Adjusted Therapy Delivery Reduces the Early Mortality Risk in Newly Diagnosed Tne Multiple Myeloma: Results of the UK Myeloma Research Alliance (UK-MRA) Myeloma XIV Fitness Trial. [Conference abstract]